News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
163 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27455)
Month
January (2434)
February (2867)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (2333)
Day
1 (180)
2 (176)
3 (166)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (160)
24 (113)
25 (42)
27 (22)
28 (135)
29 (163)
30 (145)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
27
28
29
30
Press Releases
Secretome Therapeutics Announces Initiation of THRIVE-2 Phase 2 Clinical Study Evaluating STM-01 in Duchenne Muscular Dystrophy
September 29, 2026
·
4 min read
Press Releases
CytoHub Co-Founder Aitor Aguirre Named to Lead Cardiac Tissue Engineering at NIH’s First National Organoid Center
September 29, 2026
·
5 min read
Press Releases
Oneness Biotech Advances SNS851 to Phase 1 Multiple-Ascending Dose Evaluation for Obesity-Associated Metabolic Diseases
September 29, 2026
·
7 min read
Press Releases
Serán Bioscience Strengthens Spray Dry Capabilities with Growth Investment From Biospring Partners to Accelerate Commercial Expansion and Meet Surging Customer Demand
September 29, 2026
·
6 min read
Press Releases
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
September 29, 2026
·
7 min read
Press Releases
Rejoni Receives FDA Approval of the Juveena® Hydrogel System to Reduce Intrauterine Adhesions Following Hysteroscopic Adhesiolysis
September 29, 2026
·
5 min read
Press Releases
Kyowa Kirin and Knight Therapeutics Enter Into Exclusive Distribution Agreement for POTELIGEO® (mogamulizumab) for Cutaneous T-Cell Lymphoma (CTCL) Patients Across Latin America
September 29, 2026
·
5 min read
Press Releases
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
September 29, 2026
·
2 min read
Press Releases
ImpriMed Announces Findings on the Value of Personalized Cancer Care for Dogs
September 29, 2026
·
3 min read
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
The all-stock deal gives Summit Therapeutics enough money to see through Phase 3 trials for the PD-1/VEGF bispecific ivonescimab—but keeps the asset fully in-house without giving up licensing rights.
September 29, 2026
·
3 min read
·
Tristan Manalac
Previous
8 of 17
Next
